U.S. Pelvic Fracture Patients Treated with New CurvaFix IM Implant


2021-10-14 22:00:07 BioSpace


Novel, Curved Device Launches at Orthopaedic Trauma Association Meeting BELLEVUE, Wash.--(BUSINESS WIRE)-- CurvaFix, Inc., a developer of medical devices to repair fractures in curved bones, announced today that the CurvaFix® IM Implant is now commercially available and being launched at the upcoming Orthopaedic Trauma Association (OTA) Annual Meeting, Oct. 20-23 in Fort Worth, Texas. The company will showcase the novel CurvaFix Implant in its booth (#422) and provide updates from recent U.S. cases using the CurvaFix Implant for fixation of pelvic and acetabular fractures. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211014005138/en/ The CurvaFix® IM Implant (Photo: Business Wire) “The curved boney pathways of the pelvis can present unique surgical challenges in traumatic fracture fixation with existing devices having some limitations,” said Samir Mehta, M.D., chief of the Division of Orthopaedic Trauma and Fracture Care and associate professor in Orthopaedic Surgery at Penn Medicine. “The new CurvaFix Implant has tremendous versatility allowing surgeons to follow the natural bone shape, filling the space, and achieving a stable construct. The flexible device is implanted percutaneously across the fracture and then locked in place, going from flexible to rigid, thereby maintaining fracture reduction. The patients we’ve treated using the new implant have tolerated their surgeries well.” “With the commercial launch of the CurvaFix Implant, we believe a new clinical standard will be set in orthopedic trauma surgery for pelvic fixation and repair,” said Steve Dimmer, chief executive officer. “Our novel implantable device is the only intramedullary device capable of following the natural bone shape and filling the space within the pelvis. As such, our implant offers an option to improve pelvic trauma surgery for fracture fixation and repair that may result in less pain and improved mobility for patients compared to conventional techniques.” The company also announced the addition of David Hovda to its board of directors. Mr. Hovda is president of MedTech Advisors and the former CEO of Simplify Medical, which was acquired by NuVasive in February 2021. “I am extremely pleased to welcome Mr. Hovda to our board of directors,” said Dimmer. “He brings years of expertise as a medical device executive with deep experience in commercialization and outcome-driven innovation. He joins our board at an exciting time as we launch the CurvaFix Implant for orthopedic trauma.” Pelvic fractures affect more than 165,000 people per year in the U.S.1 Often caused by car accidents or falls, these fractures are among the most serious and technically complex injuries treated by orthopedic trauma surgeons. Current surgical techniques with straight screws can be limited by bone curvature, and surgery with bone plates can require lengthy, invasive open procedures. About CurvaFix, Inc. CurvaFix, Inc. is a privately held medical device company headquartered in Bellevue, Wash. The idea for the company germinated when the former division head of orthopedic trauma at the University of British Columbia, Clinical Professor Emeritus, Robert Meek, M.D., FRCSC, believed there was a better way to repair pelvic fractures. Today, CurvaFix is developing implantable products to improve fracture repair in curved bones. The company’s first product is the CurvaFix IM Implant, which has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). CurvaFix is a trademark of CurvaFix, Inc., registered in the U.S.  1 2021 Trauma Update, Orthopedic Network News, Volume 32, No. 2, April 2021 View source version on businesswire.com: https://www.businesswire.com/news/home/20211014005138/en/ Amy Cook Acook@curvafix.com Source: CurvaFix, Inc. The CurvaFix® IM Implant (Photo: Business Wire)   View this news release and multimedia online at: http://www.businesswire.com/news/home/20211014005138/en
新型弯曲装置在骨科创伤协会会议上发布 华盛顿州贝尔维尤----(商业网)----CurvaFix公司,一家用于修复弯曲骨骼骨折的医疗设备开发商,今天宣布CurvaFix®IM植入物现已上市,并将在即将于10月20日至23日在德克萨斯州沃思堡举行的骨科创伤协会(OTA)年会上推出。该公司将在其展台(#422)展示新型CurvaFix植入物,并提供最近美国使用CurvaFix植入物固定骨盆和髋臼骨折的病例的更新。 本新闻稿以多媒体为特色。在这里查看完整版本:https://www.businesswire.com/news/home/20211014005138/en/ Curvafix®IM植入物(图片:商业网) “在现有设备有一些局限性的情况下,骨盆弯曲的骨质通道在创伤性骨折固定中可能会带来独特的外科挑战,”宾夕法尼亚医学大学骨科创伤和骨折护理科主任兼骨科外科副教授萨米尔·梅塔医学博士说。“新的CurvaFix植入物具有巨大的多功能性,允许外科医生遵循自然骨形状,填充空间,并实现稳定的结构。柔性装置经皮植入骨折处,然后锁定在适当位置,从柔性到刚性,从而保持骨折复位。我们使用新植入物治疗的患者对手术耐受性很好。“ 首席执行官史蒂夫·迪默说:“随着CurvaFix植入物的商业上市,我们相信骨盆固定和修复的骨科创伤手术将制定一个新的临床标准。”“我们的新型植入装置是唯一能够遵循自然骨骼形状并填充骨盆内空间的髓内装置。因此,我们的植入物为改善骨盆创伤骨折固定和修复手术提供了一种选择,与传统技术相比,这可能会减少患者的痛苦,并改善患者的活动能力。“ 该公司还宣布大卫·霍夫达加入其董事会。Hovda先生是MedTech Advisors的总裁,也是Simplife Medical的前首席执行官,该公司于2021年2月被NuVassive收购。 “我非常高兴地欢迎霍夫达先生加入我们的董事会,”迪默说。“作为一名医疗设备高管,他带来了多年的专业知识,在商业化和结果驱动的创新方面有着丰富的经验。他在一个激动人心的时刻加入了我们的董事会,因为我们推出了用于骨科创伤的CurvaFix植入物。“ 在美国,骨盆骨折每年影响超过165,000人。1通常由车祸或跌倒引起,这些骨折是骨科创伤外科医生治疗的最严重和技术上最复杂的损伤之一。目前使用直螺钉的外科技术可能会受到骨弯曲的限制,而使用接骨板的外科手术可能需要长时间的、侵入性的开放手术。 关于CurvaFix公司。 CurvaFix公司是一家私人控股的医疗设备公司,总部位于华盛顿州贝尔维尤。当不列颠哥伦比亚大学前骨科创伤系主任、临床荣誉退休教授罗伯特·米克医学博士认为有更好的方法修复骨盆骨折时,该公司的想法萌芽了。今天,CurvaFix正在开发植入性产品,以改善弯曲骨的骨折修复。该公司的第一个产品是CurvaFix IM植入物,已获得美国食品药品监督管理局(FDA)的510(k)许可。 CurvaFix是CurvaFix,Inc.在美国注册的商标。 1 202 1创伤更新,骨科网络新闻,第32卷,第2期2021年4月 在businesswire.com查看源代码版本:https://www.businesswire.com/news/home/20211014005138/en/ 艾米·库克 @curvafix.com 资料来源:CurvaFix公司。 Curvafix®IM植入物(图片:商业网) 请浏览本新闻稿及多媒体联机网址: http://www.businesswire.com/news/home/20211014005138/en